According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -10,48ย โฌ. In 2022 the company made an earnings per share (EPS) of -6,96ย โฌ an increase over its 2021 EPS that were of -24,62ย โฌ.